titlesubmit dateissue date
Now showing items 42-61 of 96
From obesity to diabetes and cancer: epidemiological links and role of therapies.
Genome Sequences of Five Disinfectant-Resistant Listeria monocytogenes Strains from Two Iberian Pork-Processing Plants
Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project.
Heterodimerization of p45-p75 modulates p75 signaling: structural basis and mechanism of action
High expression of MKP1/DUSP1 counteracts glioma stem cell activity and mediates HDAC inhibitor response
Human Cortical Organoids Expose a Differential Function of GSK3 on Cortical Neurogenesis
Identification of AAV serotypes for lung gene therapy in human embryonic stem cell-derived lung organoids.
Identification of prefrontal cortex protein alterations in Alzheimer's disease
Identification of tumor-associated antigens with diagnostic ability of colorectal cancer by in-depth immunomic and seroproteomic analysis.
Immune Profiling of Gliomas Reveals a Connection with IDH1/2 Mutations, Tau Function and the Vascular Phenotype.
Impact of environmental neurotoxic: current methods and usefulness of human stem cells.
Inhibition of DYRK1A destabilizes EGFR and reduces EGFR-dependent glioblastoma growth
Lactococcus garvieae: a small bacteria and a big data world
MicroRNA dysregulation in spinal cord injury: causes, consequences and therapeutics
Midkine signaling maintains the self-renewal and tumorigenic capacity of glioma initiating cells
miR-58 family and TGF-β pathways regulate each other in Caenorhabditis elegans
Multiplexed monitoring of a novel autoantibody diagnostic signature of colorectal cancer using HaloTag technology-based electrochemical immunosensing platform
Netrin-1 in Glioblastoma Neovascularization: The New Partner in Crime?
New insights into the sensitization to nonspecific lipid transfer proteins from pollen and food: New role of allergen Ole e 7.
Newcastle Disease Virus (NDV) Oncolytic Activity in Human Glioma Tumors Is Dependent on CDKN2A-Type I IFN Gene Cluster Codeletion.